CI	Confidence interval
CR	Complete response
DCR	Disease control rate
ECOG	Eastern Cooperative Oncology Group
HR	Hazard ratio
ICI	Immune checkpoint inhibitor
IHC	Immunohistochemistry
IQR	Interquartile range
NSCLC	Non-small cell lung cancer
ORR	Objective response rate
PD	Progressive disease
PD-1	Programmed cell death protein 1
PD-L1	Programmed death-ligand 1
PFS	Progression-free survival
PR	Partial response
RECIST	Response Evaluation Criteria in Solid Tumors
RMST	Restricted mean survival time
SD	Stable disease
TMB	Tumor mutational burden
TPS	Tumor proportion score
TTP	Time to progression